Shares of popular vaccine makers fell on Thursday after President-elect Donal Trump announced his decision to nominate vaccine skeptic Robert F. Kennedy Jr. to run the Department of Health and Human Services (“HHS”).
Though this nomination was officially confirmed on Trump’s social media accounts after market close, news reports of RFK Jr. having a prominent role in federal health agencieshave been circulating ever since Trump won the elections.
In a social media post, Kennedy accepted the offer and committed to advancing Trump’s vision to ‘Make America Healthy Again.’
In response to the news, shares of Moderna MRNA were down nearly 6%. Pfizer PFE stock fell almost 3%. Shares of Novavax NVAX and BioNTech BNTX also lost 7% each. Shares of European drugmakers GSK and Sanofi also lost 2% and 3.4%, respectively.
Robert F. Kennedy Jr. is one of the most prominent anti-vaccine activists in the country and has been called out for spreading misinformation and false propaganda on vaccines. He is also the founder of the non-profit anti-vaccine organization Children’s Health Defense.
Investors have expressed concerns about the falling COVID-19 vaccination rates in the country, which has negatively impacted the top and bottom lines of Moderna, Pfizer, BioNTech and Novavax over the last couple of years.
Nominating RFK Jr. as the head of HHS might allow him to advance his anti-vaccine theories and even bring some major changes in public health policies. This could potentially discourage more American citizens from getting routine shots for COVID-19 and influenza. This could have a further denting impact on the financials of these vaccine-makers.
Kennedy was a candidate for the Presidential election this season before dropping out of the race and extending his support to Trump.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Pfizer Inc. (PFE) : Free Stock Analysis Report
Moderna, Inc. (MRNA) : Free Stock Analysis Report
Novavax, Inc. (NVAX) : Free Stock Analysis Report
BioNTech SE Sponsored ADR (BNTX) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。